Objective: The purpose of this study was to evaluate the feasibility and safety in terms of prognostic significance and perioperative morbidity and mortality of cytoreduction in patients affected by advance ovarian cancer and hepato-biliary metastasis. Methods: Patients with a least one hepatobiliary metastasis who have undergone surgical treatment with curative intent of were considered for the study. Perioperative complications were evaluated and graded with Accordion severity Classification. Five-year PFS and OS were estimated using the Kaplan–Meier curve. Results: Sixty-seven (20.9%) patients had at least one metastasis to the liver, biliary tract, or porta hepatis. Forty-four (65.7%) and 23 (34.3%) patients underwent respectively high and intermediate complexity surgery according. Complete cytoreduction was achieved in 48 (71.6%) patients with hepato-biliary disease. In two patients (2.9%) severe complications related to hepatobiliary surgery were reported. The median PFS for the patients with hepato-biliary involvement (RT = 0 vs. RT > 0) was 19 months [95% confidence interval (CI) 16.2–21.8] and 8 months (95% CI 6.1–9.9). The median OS for the patients with hepato-biliary involvement (RT = 0 vs. RT > 0) 45 months (95% CI 21.2–68.8 months) and 23 months (95% CI 13.9–32.03). Conclusions: Hepatobiliary involvement is often associated with high tumor load and could require high complex multivisceral surgery. In selected patients complete cytoreduction could offer survival benefits. Morbidity related to hepatobiliary procedures is acceptable. Careful evaluation of patients and multidisciplinary approach in referral centers is mandatory.

Hepatobiliary disease resection in patients with advanced epithelial ovarian cancer: prognostic role and optimal cytoreduction / Di Donato, V.; Giannini, A.; D'Oria, O.; Schiavi, M. C.; Di Pinto, A.; Fischetti, M.; Lecce, F.; Perniola, G.; Battaglia, F.; Berloco, P.; Muzii, L.; Benedetti Panici, P.. - In: ANNALS OF SURGICAL ONCOLOGY. - ISSN 1068-9265. - 28:1(2021), pp. 222-230. [10.1245/s10434-020-08989-3]

Hepatobiliary disease resection in patients with advanced epithelial ovarian cancer: prognostic role and optimal cytoreduction

Di Donato V.;Giannini A.;D'Oria O.;Schiavi M. C.;Di Pinto A.;Fischetti M.;Lecce F.;Perniola G.;Battaglia F.;Berloco P.;Muzii L.;Benedetti Panici P.
2021

Abstract

Objective: The purpose of this study was to evaluate the feasibility and safety in terms of prognostic significance and perioperative morbidity and mortality of cytoreduction in patients affected by advance ovarian cancer and hepato-biliary metastasis. Methods: Patients with a least one hepatobiliary metastasis who have undergone surgical treatment with curative intent of were considered for the study. Perioperative complications were evaluated and graded with Accordion severity Classification. Five-year PFS and OS were estimated using the Kaplan–Meier curve. Results: Sixty-seven (20.9%) patients had at least one metastasis to the liver, biliary tract, or porta hepatis. Forty-four (65.7%) and 23 (34.3%) patients underwent respectively high and intermediate complexity surgery according. Complete cytoreduction was achieved in 48 (71.6%) patients with hepato-biliary disease. In two patients (2.9%) severe complications related to hepatobiliary surgery were reported. The median PFS for the patients with hepato-biliary involvement (RT = 0 vs. RT > 0) was 19 months [95% confidence interval (CI) 16.2–21.8] and 8 months (95% CI 6.1–9.9). The median OS for the patients with hepato-biliary involvement (RT = 0 vs. RT > 0) 45 months (95% CI 21.2–68.8 months) and 23 months (95% CI 13.9–32.03). Conclusions: Hepatobiliary involvement is often associated with high tumor load and could require high complex multivisceral surgery. In selected patients complete cytoreduction could offer survival benefits. Morbidity related to hepatobiliary procedures is acceptable. Careful evaluation of patients and multidisciplinary approach in referral centers is mandatory.
2021
cytoreduction; ovarian cancer; hepato-biliary metastasis; perioperative complications
01 Pubblicazione su rivista::01a Articolo in rivista
Hepatobiliary disease resection in patients with advanced epithelial ovarian cancer: prognostic role and optimal cytoreduction / Di Donato, V.; Giannini, A.; D'Oria, O.; Schiavi, M. C.; Di Pinto, A.; Fischetti, M.; Lecce, F.; Perniola, G.; Battaglia, F.; Berloco, P.; Muzii, L.; Benedetti Panici, P.. - In: ANNALS OF SURGICAL ONCOLOGY. - ISSN 1068-9265. - 28:1(2021), pp. 222-230. [10.1245/s10434-020-08989-3]
File allegati a questo prodotto
File Dimensione Formato  
DiDonato_Hepatobiliary-disease-resection_2020.pdf

accesso aperto

Tipologia: Licenza (contratto editoriale)
Licenza: Creative commons
Dimensione 328.72 kB
Formato Adobe PDF
328.72 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1480924
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 15
social impact